Anika Therapeutics Inc. | Mutual Funds

Mutual Funds that own Anika Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Core S&P Small Cap ETF
821,182
5.63%
231
0.07%
09/06/2018
Vanguard Total Stock Market Index Fund
358,057
2.46%
0
0%
07/31/2018
Virtus Quality Small Cap Fund
309,790
2.12%
0
2.44%
06/29/2018
iShares Russell 2000 ETF
307,042
2.11%
-165
0.03%
09/06/2018
DFA US Small Cap Portfolio
205,607
1.41%
3,100
0.04%
04/30/2018
Vanguard Extended Market Index Fund
200,402
1.37%
-45
0.01%
07/31/2018
DFA US Micro Cap Portfolio
178,766
1.23%
764
0.08%
04/30/2018
PowerShares S&P Small Cap Health Care Portfolio
168,956
1.15%
10,747
0.56%
09/05/2018
SPDR S&P Health Care Equipment ETF
153,169
1.05%
0
0.86%
09/06/2018
Wanger USA Fund
149,150
1.02%
26,799
0.75%
03/31/2018

About Anika Therapeutics

View Profile
Address
32 Wiggins Avenue
Bedford Massachusetts 01730
United States
Employees -
Website http://www.anikatherapeutics.com
Updated 07/08/2019
Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary.